Daniel Moreno Berggren
Research physician at Department of Medical Sciences; Haematology
- E-mail:
- daniel.moreno_berggren@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ing 101, plan 4
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ing 100, plan 2
751 85 Uppsala
Publications
Recent publications
-
Part of British Journal of Haematology, p. 514-523, 2026
- DOI for Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia: a population-based study
- Download full text (pdf) of Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia: a population-based study
-
Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
Part of Leukemia, p. 1103-1112, 2023
- DOI for Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
- Download full text (pdf) of Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
-
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
Part of Leukemia Research, 2023
- DOI for MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
- Download full text (pdf) of MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
-
2023
-
Part of European Journal of Haematology, p. 219-228, 2021
- DOI for Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes
- Download full text (pdf) of Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes
All publications
Articles in journal
-
Part of British Journal of Haematology, p. 514-523, 2026
- DOI for Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia: a population-based study
- Download full text (pdf) of Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia: a population-based study
-
Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
Part of Leukemia, p. 1103-1112, 2023
- DOI for Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
- Download full text (pdf) of Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
-
MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
Part of Leukemia Research, 2023
- DOI for MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
- Download full text (pdf) of MDS-Comorbidity Index using register data has prognostic impact in Swedish MDS patients
-
Part of European Journal of Haematology, p. 219-228, 2021
- DOI for Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes
- Download full text (pdf) of Income, education and their impact on treatments and survival in patients with myelodysplastic syndromes
-
Part of British Journal of Haematology, p. 474-483, 2021
- DOI for Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study
- Download full text (pdf) of Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study
-
Part of British Journal of Haematology, p. 614-627, 2018
-
Validation Of Prognostic Scoring Systems For Myelodysplastic Syndromes In The Swedish Mds-Register
Part of Haematologica, p. 243-243, 2016